drugset / Trial / NCT00893139

A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye

NCT00893139 ↗

Phase 2 Completed 765 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether AL-38583 ophthalmic solution is effective for treatment of signs and symptoms of dry eye.

Timeline

Start
2009-06
Primary completion
2010-01
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject AL-38583 Unknown 0.05 % Other
Subject AL-38583 Unknown 0.1 % Other

Indications